The impact of overweight on lipid phenotype in different forms of dyslipidemia: a retrospective cohort study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
The impact of overweight on lipid phenotype in different forms of dyslipidemia: a retrospective cohort study ; day:11 ; month:4 ; year:2024 ; pages:1-8
Journal of endocrinological investigation ; (11.4.2024), 1-8
- Creator
-
Formisano, E.
Proietti, E.
Borgarelli, C.
Sukkar, S. G.
Albertelli, M.
Boschetti, M.
Pisciotta, L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40618-024-02368-5
- URN
-
urn:nbn:de:101:1-2406251035321.148991828648
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Formisano, E.
- Proietti, E.
- Borgarelli, C.
- Sukkar, S. G.
- Albertelli, M.
- Boschetti, M.
- Pisciotta, L.
- SpringerLink (Online service)
Other Objects (12)
Prevalence and Control of Dyslipidemia in Patients Referred for High Blood Pressure: The Disregarded “Double-Trouble” Lipid Profile in Overweight/Obese
Height correlates with dyslipidemia in non-overweight middle-aged Japanese men
Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA)
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Deficiency of the lipid flippase ATP10A causes diet-induced dyslipidemia in female mice
Lipid profile and dyslipidemia among school-age children in urban Ghana
Diabetes Dyslipidemia
Modeling the risk factors for dyslipidemia and blood lipid indices: Ravansar cohort study
Assessment of Dyslipidemia, Lipid Ratios, and Atherogenic Indices as Cardiovascular Risk Factors in Prediabetic and Diabetic Subjects
Worldwide Dyslipidemia Guidelines
The role of CETP inhibition in dyslipidemia
Safety of Prescribing Statins in Childhood Dyslipidemia
Prevalence and Control of Dyslipidemia in Patients Referred for High Blood Pressure: The Disregarded “Double-Trouble” Lipid Profile in Overweight/Obese
Height correlates with dyslipidemia in non-overweight middle-aged Japanese men
Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA)
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Deficiency of the lipid flippase ATP10A causes diet-induced dyslipidemia in female mice
Lipid profile and dyslipidemia among school-age children in urban Ghana
Diabetes Dyslipidemia
Modeling the risk factors for dyslipidemia and blood lipid indices: Ravansar cohort study
Assessment of Dyslipidemia, Lipid Ratios, and Atherogenic Indices as Cardiovascular Risk Factors in Prediabetic and Diabetic Subjects
Worldwide Dyslipidemia Guidelines
The role of CETP inhibition in dyslipidemia
Safety of Prescribing Statins in Childhood Dyslipidemia
Prevalence and Control of Dyslipidemia in Patients Referred for High Blood Pressure: The Disregarded “Double-Trouble” Lipid Profile in Overweight/Obese
Height correlates with dyslipidemia in non-overweight middle-aged Japanese men
Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA)
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Deficiency of the lipid flippase ATP10A causes diet-induced dyslipidemia in female mice
Lipid profile and dyslipidemia among school-age children in urban Ghana
Diabetes Dyslipidemia
Modeling the risk factors for dyslipidemia and blood lipid indices: Ravansar cohort study
Assessment of Dyslipidemia, Lipid Ratios, and Atherogenic Indices as Cardiovascular Risk Factors in Prediabetic and Diabetic Subjects
Worldwide Dyslipidemia Guidelines
The role of CETP inhibition in dyslipidemia